An overview of optimal endovascular strategy in treating the femoropopliteal artery: mechanical, biological, and procedural factors.
Treatment of the femoropopliteal (FP) artery remains a challenge to the endovascular specialist. Long-term patency is low with a high rate of target lesion revascularization. The true patency rate varies considerably between studies partly because there is a lack of uniform performance criteria and reporting standards in peripheral arterial interventions. Literature review supports three principles that emerge as important components of an optimal strategy in treating the FP artery: (1) improving vessel compliance and subsequently less dissections and bailout stenting, (2) reducing smooth muscle cell proliferation, and (3) protecting outflow vessels from distal embolization. In this overview, we examine current data that support the validity of this strategy.
Midwest Cardiovascular Research Foundation, Davenport, Iowa.
Nicolas W
NW
Shammas
atherectomy; distal embolization; drug-coated balloon; femoropopliteal artery; in-stent restenosis; restenosis; tibial runoff